Andere Sprachen Pharmadrug Inc.

Aktien

A3EURE

CA71716W2040

PHRX

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 21:14:13 02.05.2024			% 5 Tage	% 1. Jan.
0,03 ^CAD	0,00 %		0,00 %	-45,45 %

13.03.	Pharmadrug's SecureDose gibt die Einreichung eines vorläufigen US-Patents für ein Herstellungsverfahren für biosynthetisches Kokain in pharmazeutischer Qualität bekannt	CI
28.02.	PharmaDrug Inc kündigt Änderungen im Vorstand an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PharmaDrug Announces Director Appointment and Resignation	22:45
PharmaTher's Sairiyo Therapeutics Completes Regulatory Package For Phase 1 Study of Reformulated Cepharanthine in Australia	01.05.
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine	01.05.
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine	16.04.
PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine	16.04.
Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13.03.
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine	13.03.
PharmaDrug Inc Announces Board Changes	28.02.
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman	27.02.
PharmaTher Provides Update For PD-001	21.02.
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies	14.02.
Pharmadrug Inc. Announces Marketing and Distribution Services Agreement with Outside the Box Capital Inc	12.02.
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers	12.02.
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement	08.02.
Pharmadrug Inc. announced that it has received CAD 0.326 million in funding	08.02.
PharmaDrug Inc. Announces Proposed Non-Brokered Private Placement	01.02.
Pharmadrug Inc. announced that it expects to receive CAD 0.326 million in funding	01.02.
PharmaDrug CEO Provides Vision for Securedose Acquisition	13.12.
PharmaDrug Inc. Completes Debt Restructuring	15.11.
PharmaDrug Inc. Announces Grant of Stock Options	08.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Pharmadrug Inc.

Aktien

A3EURE

CA71716W2040

PHRX

Andere Sprachen

Filter